First Manhattan CO Becton Dickinson & CO Transaction History

First Manhattan CO

  • $35.3 Billion
  • Q3 2025

A detailed history of First Manhattan CO transactions in Becton Dickinson & CO stock. As of the latest transaction made, First Manhattan CO holds 2,831 shares of BDX stock, worth $540,664. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,831
Previous 2,966 4.55%
Holding current value
$540,664
Previous $510,000 3.73%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
SELL
$172.41 - $199.66 $23,275 - $26,954
-135 Reduced 4.55%
2,831 $529,000
Q2 2025

Aug 14, 2025
SELL
$165.15 - $226.42 $3,798 - $5,207
-23 Reduced 0.77%
2,966 $510,000
Q1 2025

May 15, 2025
SELL
$222.79 - $249.08 $17,154 - $19,179
-77 Reduced 2.51%
2,989 $684,000
Q3 2024

Nov 14, 2024
SELL
$221.47 - $242.41 $110,735 - $121,205
-500 Reduced 14.02%
3,066 $739,000
Q1 2024

May 15, 2024
SELL
$233.45 - $247.73 $466 - $495
-2 Reduced 0.06%
3,566 $882,000
Q4 2023

Feb 13, 2024
SELL
$232.24 - $267.23 $88,947 - $102,349
-383 Reduced 9.69%
3,568 $869,000
Q3 2023

Nov 14, 2023
SELL
$254.9 - $283.59 $4.9 Million - $5.45 Million
-19,206 Reduced 82.94%
3,951 $1.02 Million
Q2 2023

Aug 14, 2023
SELL
$238.39 - $265.32 $881,327 - $980,888
-3,697 Reduced 13.77%
23,157 $6.11 Million
Q1 2023

May 15, 2023
SELL
$229.71 - $259.35 $215,238 - $243,010
-937 Reduced 3.37%
26,854 $6.65 Million
Q4 2022

Feb 14, 2023
BUY
$218.29 - $256.91 $33,398 - $39,307
153 Added 0.55%
27,791 $7.07 Million
Q3 2022

Nov 14, 2022
SELL
$51.03 - $264.23 $10,410 - $53,902
-204 Reduced 0.73%
27,638 $6.16 Million
Q2 2022

Aug 15, 2022
SELL
$234.74 - $275.42 $23,474 - $27,542
-100 Reduced 0.36%
27,842 $6.86 Million
Q1 2022

May 16, 2022
SELL
$243.64 - $270.48 $405,173 - $449,808
-1,663 Reduced 5.62%
27,942 $7.43 Million
Q4 2021

Feb 14, 2022
BUY
$230.08 - $250.94 $1.32 Million - $1.44 Million
5,729 Added 23.99%
29,605 $7.45 Million
Q3 2021

Nov 15, 2021
SELL
$232.72 - $256.47 $83,081 - $91,559
-357 Reduced 1.47%
23,876 $5.87 Million
Q2 2021

Aug 16, 2021
SELL
$232.65 - $254.58 $214,270 - $234,468
-921 Reduced 3.66%
24,233 $5.89 Million
Q1 2021

May 14, 2021
SELL
$232.09 - $256.88 $50,827 - $56,256
-219 Reduced 0.86%
25,154 $6.12 Million
Q4 2020

Feb 16, 2021
SELL
$221.92 - $245.94 $331,992 - $367,926
-1,496 Reduced 5.57%
25,373 $6.35 Million
Q3 2020

Nov 12, 2020
SELL
$215.77 - $276.76 $531,441 - $681,659
-2,463 Reduced 8.4%
26,869 $6.25 Million
Q2 2020

Aug 14, 2020
BUY
$219.9 - $263.41 $65,090 - $77,969
296 Added 1.02%
29,332 $7.02 Million
Q1 2020

May 06, 2020
BUY
$195.69 - $279.01 $302,341 - $431,070
1,545 Added 5.62%
29,036 $6.67 Million
Q3 2019

Nov 13, 2019
BUY
$230.58 - $256.08 $279,693 - $310,625
1,213 Added 4.62%
27,491 $6.95 Million
Q1 2019

Apr 12, 2019
BUY
$206.05 - $248.17 $70,675 - $85,122
343 Added 1.32%
26,278 $6.56 Million
Q4 2018

Jan 30, 2019
SELL
$204.73 - $257.93 $168,902 - $212,792
-825 Reduced 3.08%
25,935 $5.84 Million
Q3 2018

Oct 15, 2018
SELL
$233.07 - $256.0 $9,322 - $10,240
-40 Reduced 0.15%
26,760 $6.98 Million
Q2 2018

Aug 01, 2018
SELL
$208.1 - $233.85 $166,480 - $187,080
-800 Reduced 2.9%
26,800 $6.42 Million
Q1 2018

Apr 20, 2018
SELL
$205.46 - $240.27 $300,793 - $351,755
-1,464 Reduced 5.04%
27,600 $5.98 Million
Q4 2017

Jan 22, 2018
BUY
$189.0 - $222.64 $1.29 Million - $1.52 Million
6,808 Added 30.59%
29,064 $6.22 Million
Q3 2017

Oct 25, 2017
BUY
$186.89 - $198.9 $4.16 Million - $4.43 Million
22,256
22,256 $4.36 Million

Others Institutions Holding BDX

# of Institutions
1,717
Shares Held
257M
Call Options Held
1.01M
Put Options Held
544K
View Full List

About BECTON DICKINSON & CO

BDX Quotes by TradingView
  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $54.5B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track First Manhattan CO Portfolio

Follow First Manhattan CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

News

Stay updated on First Manhattan CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email